Amgen was honored with the “Excellence in Supplier Diversity” award from the Southern California Minority Supplier Development Council (SCMSDC). This award recognizes supplier diversity programs that are going above and beyond to promote the inclusion of small/diverse suppliers, showing year-over-year improvement in supplier diversity initiatives and demonstrates a commitment to the development of small/diverse suppliers.
Amgen’s Janet Franklin, Vice President of Global Development, has been named one of the “Fiercest Women in Life Sciences” by Fierce Pharma. According to the publication, “The women on our list are all filled with a fire that has kept them plowing ahead, driven by a goal of developing medicines and technologies that could save millions of lives around the world—and redrawing the image of leadership in the process.
Amgen has been named one of the “Best Places to Work” by BioSpace, which notes that “the most desirable companies offer workplace flexibility—namely remote work options, work-home balance awareness, cultures of inclusion and progressive diversity, equity and inclusion (DEI) policies.”
Amgen has been named a “Humankind 100” company by Humankind Investments, which has a mission “to invest in the manner that is best for humanity.” James Katz, founder and CEO of Humankind Investments, said, “We launched the Humankind 100 with a two-fold purpose – to help people understand the companies best supporting their quality of life and to encourage companies to continue striving for progress.”
Amgen received a prestigious Prix Galien award for a new medicine to treat a particular form of lung cancer that for 40 years was considered to be “undruggable.” Dr. Sue Desmond-Hellmann, Chair of the Prix Galien USA and Prix Galien International Award Committees and former CEO of the Bill & Melinda Gates Foundation, said, “We thank all nominees and winners for their continued ingenuity and perseverance in the advancement of science, healthcare, and wellness, globally.”
Amgen received the prestigious Charles A. Sanders, M.D. Partnership Award from the Foundation of the National Institutes of Health (FNIH). Dr. Francis Collins, former NIH Director, was given the same honor. “The FNIH’s partnerships bring together the public and private sectors to advance groundbreaking biomedical research,” said Julie L. Gerberding, M.D., CEO of the FNIH. “Dr. Francis Collins and Amgen represent the best of our partners interested in working collaboratively to improve the lives of patients.” Amgen CEO Bob Bradway accepted the award, saying, “Amgen’s work with the FNIH is an outstanding example of partnership in service of innovation.”
Amgen’s Ai Ching Lim and Samantha Palmer have been named to the San Francisco Business Times’ list of the “Most Influential Women in Bay Area Business.” Both work to bring the best innovation to Amgen, Lim through internal research and Palmer through external business development.
Amgen has been recognized by Fast Company as one of the “World’s Most Innovative Companies.” According to Fast Company Deputy Editor David Lidsky, “The world’s most innovative companies play an essential role in addressing the most pressing issues facing society.” Amgen was cited for the discovery and development of a new treatment for non-small cell lung cancer with a particular genetic mutation. Today, this medicine has been approved in major markets around the world, offering new hope to patients.
Amgen has been recognized as a Disability Equality Index (DEI) “Best Places to Work for Disability Inclusion.” With a top score, the honor acknowledges Amgen’s commitment to disability equality and inclusion, as well as to broader social issues such as supplier diversity and community engagement. The DEI is one of the most comprehensive benchmarking tools used by Fortune 1000 companies to measure disability workplace inclusion against competitors, including employment practices, and culture and leadership.
Amgen has been named to this list by Careers and the disAbled Magazine, which asks its readers to “name the companies for which they’d most like to work or which they believe would provide a positive working environment for people with disabilities.”
For the fifth straight year, Amgen was named one of “America's Most JUST Companies” by JUST Capital and CNBC. The rankings are based on how companies treat their employees, communities, customers, and other stakeholders. “We’ve entered a new era of accountability where employees, customers, and investors want to understand if companies are not just talking the talk, but walking the walk to drive change on the critical issues of our time,” said Martin Whittaker, CEO of JUST Capital. “The companies featured in the 2022 JUST 100 are demonstrating that purpose and profits can go hand in hand by delivering value to all stakeholders, including shareholders.”
Savoy magazine has named Amgen’s Dr. Ponda Motsepe-Ditshego as one of the “Most Influential Black Executives in Corporate America.” According to LP Green II, publisher of Savoy, “These innovative trailblazers have led efforts to foster growth for some of the country’s highest-performing companies throughout and beyond the U.S. market.” Dr. Motsepe-Ditshego has been a driving force behind Amgen’s efforts to improve the diversity of patients participating in clinical trials for potential new medicines.
Amgen has been named one of the “World’s Best Employers” by Forbes. The magazine partnered with market research firm Statista to survey 150,000 full-time and part-time workers from 57 countries working for multinational companies and institutions. Survey respondents were asked to rate their willingness to recommend their own employers to friends and family, and to evaluate other employers in their respective industries that stood out either positively or negatively. Participants were asked to rate the companies on aspects such as economic impact and image, talent development, gender equality and social responsibility. The 800 companies that received the highest total scores made the final list.
Amgen has been named one of “America’s Best Employers for Diversity” by Forbes. The magazine partnered with market research firm Statista to survey 60,000 Americans working for businesses with at least 1,000 employees. Survey participants were asked to rate their organizations on criteria such as age, gender, ethnicity, disability and sexual orientation equality, as well as that of general diversity. More than 10,000 companies were reviewed, with the top 500 making the list.
Amgen has been named one of “America’s Best Employers for New Grads” by Forbes. The magazine partnered with market research firm Statista to survey 20,000 Americans with less than 10 years of professional experience who work for businesses with at least 1,000 employees. Respondents were asked to rate their employers on a variety of criteria, including safety of work environment, competitiveness of compensation, opportunities for advancement, effectiveness of diversity and inclusion efforts, and company image. The top 300 companies made the list, with Amgen ranking #72.
Amgen has been named one of “America’s Best Employers for Women” by Forbes. The magazine partnered with market research company Statista to “identify the companies that are leading the way in supporting women inside and outside their workforces.” The women surveyed rated their employers on factors such as parental leave, discrimination and pay equity. Representation at the executive and board levels were also factored into the results.
Amgen has been named one of “America’s Best Large Employers” by Forbes, placing 81st among the 500 companies making the list. To determine the list, 60,000 Americans were asked to rate how likely they’d be to recommend their employer, and also to rate their employers on factors such as working conditions, development opportunities, and compensation.
Amgen has been named one of the best employers in California by Forbes magazine. The company was founded in Thousand Oaks, California, more than 40 years ago and its world headquarters are still there today. According to Forbes, “While many of the hallmarks of a top employer are universal—such as fair pay, safe working conditions, and an inclusive culture—other priorities have emerged in recent years. The Covid-19 pandemic and heightened awareness of racial injustice have shifted expectations of employers. For that reason, the survey included more questions about remote-work benefits, the wage gap for women and initiatives around diversity, equity and inclusion.”
Jon Graham, who is responsible for leading Amgen’s global Law function, has received the 2022 Corporate Leadership Award from The International Institute for Conflict Prevention and Resolution (CPR). “Amgen and Jon have been leaders in finding better ways to resolve legal disputes for many years,” said Allen Waxman, President and CEO of CPR. “Adoption and consistent use of alternative dispute resolution tools has allowed its business leaders to focus on growth and innovation, so it is no surprise that today Amgen is one of the world’s leading biotechnology companies.”
Amgen has appeared on the list of “America’s Most Responsible Companies” compiled by Newsweek magazine and the global research Statista for three consecutive years. According to Nancy Cooper, Newsweek’s Global Editor in Chief, “Corporations aren't just impersonal machines for making money; they are also members of the communities where their employees, customers and neighbors live and work. Some, of course, take their environmental and social responsibilities as citizens of the country and of the world more seriously than others.”
Amgen received the 2022 Hope Award for Corporate Leadership from the LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization. The award is presented to a company that has demonstrated exceptional commitment to lung cancer communities in the U.S. and globally. “Amgen is a true partner to the patient community and has been instrumental in supporting impactful LUNGevity programs that are working to improve how people live with lung cancer,” said Andrea Ferris, president and CEO of LUNGevity.
Amgen has been named one of “America’s 100 Most Sustainable Companies” by Barron’s and Calvert Research and Management. To create the list, the 1,000 largest publicly traded companies by market value were evaluated by how they performed for five key constituencies: shareholders, employees, customers, community, and the planet. The top 100 companies make the list. “We’re seeing a real operational implementation of sustainability across these companies, real operational progress,” says John Streur, CEO of Calvert Research and Management.
Amgen has earned a perfect score – for the sixth year in a row – on the 2022 Corporate Equality Index (CEI), a national benchmarking tool administered by the Human Rights Campaign Foundation, the educational arm of the nation's largest LGBTQ+ civil rights organization. “Since its launch in 2002, employees, consumers and investors have used the CEI as a comprehensive tool to determine what a company’s policies are before they accept a job, buy a product or invest their money,” said Joni Madison, Interim President of the Human Rights Campaign Foundation.
Amgen is named one of the “JUST 100” by Forbes and JUST Capital in their annual rankings of America’s Most Just Companies. To produce the rankings, JUST Capital polled over 100,000 Americans on key issues that define just business behavior, and then ranked companies on the high-priority issues.
Amgen ranked number 37 on The Wall Street Journal’s annual list of the 250 best-managed companies for 2021. The WSJ's Management Top 250 ranking, developed by the Drucker Institute, measures corporate effectiveness across five key areas: customer satisfaction, employee engagement and development, innovation, social responsibility and financial strength.
Amgen ranked among the top biotech companies in corporate responsibility with its inclusion on the 2021 Dow Jones Sustainability Indices (DJSI) World Index for the eighth year in a row. Amgen was also included on the DJSI North America Index for the ninth consecutive year. The DJSI Indices are among the most robust and reliable indicators of a company's sustainability performance due to the breadth of companies included, and the extensive and rigorous nature of their annual sustainability assessment.
Amgen came in at number 68 on the list of America's Most Responsible Companies 2021 from Newsweek and Statista. The list comprised 399 companies across dozens of industries, recognizing their efforts to be good corporate citizens and give back to the communities they operate in.
Amgen was recently rated as one of the leading companies in the U.S. for workplace health and wellness in the 2021 American Heart Association's (AHA) Workplace Health Achievement Index, qualifying for Gold Recognition. The American Heart Association has defined best practices for employers to use to build a culture of health for their employees in the workplace. The American Heart Association's Workplace Health Achievement Index measures the extent to which the company has implemented those workplace health best practices. Companies recognized at the Gold level have achieved an Index score of 175 to 217 out of a maximum 217 points.
Amgen has again earned a perfect score of 100% on the 2021 Corporate Equality Index, a national benchmarking tool on corporate policies and practices related to lesbian, gay, bisexual, transgender and queer (LGBTQ) workplace equality. The CEI is administered by the Human Rights Campaign (HRC) Foundation, the educational arm of the nation's largest LGBTQ civil rights organization.
The Human Rights Campaign Foundation also recognized Amgen as among the 767 businesses that met all the criteria to earn a 100% rating on its 2021 Corporate Equality Index, which earned Amgen the designation of being a 2021 "Best Place to Work for LGBTQ Equality."
Amgen was ranked as the seventh best workplace in Europe, making the list for the fifth time with its highest ranking ever. Twenty five Amgen affiliates have either been certified or recognized by Great Place to Work® internationally. This includes 13 affiliates in Europe, as well as Algeria, Brazil, Colombia, Egypt, Kuwait, Mexico, Morocco, Saudi Arabia, Singapore, South Africa, Turkey and the United Arab Emirates.
Amgen ranked 12 out of 144 companies surveyed by Military Times in the "Best Place for Vets: Employers" ranking for 2021. This survey is the most comprehensive annual ranking of the country's best employers and organizations with military-connected employment programs, benefits and support efforts.
Amgen received a Military Friendly designation from Military Friendly®, a standard that measures an organization's commitment, effort, and success in creating sustainable and meaningful benefits for the military community. Over 1,500 organizations compete annually for Military Friendly® designations. The standard is owned by Viqtory, Inc., a service-disabled, veteran-owned small business.
Amgen ranked as one of Barron's 100 most sustainable companies for 2021. In creating the list, the respected financial publication looked at more than 230 ESG indicators, including workplace diversity and greenhouse-gas emissions. The 100 companies on the Barron's list have outperformed the S&P 500 index in each of the past three years on a market-weighted basis.
Amgen placed at number 145 on Forbes Magazine's America's Best Employers for Diversity list in 2021. The ranking is created from a survey of 50,000 U.S. employees on their perceptions of companies' diversity & inclusion initiatives, gender split of senior management and board members and proactive diversity communications.
Amgen was included at number 95 on Forbes Magazine's America's Best Employers for New Graduates list. The list was compiled by surveying 20,000 Americans with less than 10 years of experience working for businesses with at least 1,000 employees.
In 2020, Amgen joined the Dow Jones Industrial Average. an internationally recognized metric for evaluating the overall performance of the U.S. stock market.
Amgen is named one of the “JUST 100” by Forbes Magazine and Just Capital in their 2020 rankings of America’s Most Just Companies. To produce the rankings, Just Capital identified and polled Americans on key issues and priorities that define just business behavior.
Institutional Investor magazine published its 2021 All-America Executive Team Rankings and Amgen took the top spot in all four categories: Best CEO (Bob Bradway), Best CFO (Peter Griffith), Best Investor Relations Professional (Arvind Sood) and Best Investor Relations Program in the biotechnology sector.
Amgen ranked among the top biotech companies in corporate responsibility with its inclusion on the 2020 Dow Jones Sustainability Indices (DJSI) World Index for the seventh year in a row. Amgen was also included on the DJSI North America Index for the eighth consecutive year. The DJSI Indices are among the most robust and reliable indicators of a company’s sustainability performance due to the breadth of companies included, and the extensive and rigorous nature of their annual sustainability assessment.
Amgen was recently rated as one of the leading companies in the U.S. for workplace health and wellness in the 2020 American Heart Association’s (AHA) Workplace Health Achievement Index, qualifying for Gold Recognition. The American Heart Association has defined best practices for employers to use to build a culture of health for their employees in the workplace. The American Heart Association’s Workplace Health Achievement Index measures the extent to which the company has implemented those workplace health best practices. Companies recognized at the Gold level have achieved an Index score of 175 - 217 out of a maximum 217 points.
Amgen has again earned a perfect score of 100% on the 2020 Corporate Equality Index (CEI), a national benchmarking tool on corporate policies and practices related to lesbian, gay, bisexual, transgender and queer (LGBTQ) workplace equality. The CEI is administered by the Human Rights Campaign (HRC) Foundation, the educational arm of the nation’s largest LGBTQ civil rights organization.
Amgen was honored as best workplace in Europe 2020 by the Great Place to Work Institute ranking #13 among multinationals and #3 in the biotechnology category. Great Place to Work® assesses organizations and selects great workplaces based on employees’ perceptions of their workplace experience and an analysis of the practices that underpin the organization’s workplace culture.
Amgen ranked #12 out of #144 companies surveyed by Military Times in the “Best Place for Vets: Employers” ranking for 2020. This survey is the most comprehensive annual ranking of the country's best employers and organizations with military-connected employment programs, benefits and support efforts.
Amgen was honored as one of the top biotechnology companies for women by InHerSight. In 2020, Amgen ranked #6 on InHerSight’s Best Biotechnology Companies to Work For list. InHerSight's list of the best biotechnology companies for women is based on millions of anonymous employer ratings and reviews from working women.
Amgen was recently honored by Providence Business News Manufacturing Awards 2020 for Collaboration in Manufacturing Excellence.
Amgen has been named #5 on Fast Company’s list of the 10 Most Innovative Companies in Biotech for 2019.
Amgen was ranked #22 on Indeed’s 2019 Top-Rated Workplace List. Indeed identified this year’s 50 Top-Rated Workplaces by looking at their 150 million employer ratings and reviews and analyzing those from companies also featured on this year’s Fortune 500 list. Visit the Indeed blog to learn more.
Amgen ranked among the top biotech companies in corporate responsibility with its inclusion on the 2019 Dow Jones Sustainability Indices (DJSI) World Index for the sixth year in a row. Amgen was also included on the DJSI North America Index for the seventh consecutive year. The DJSI Indices are among the most robust and reliable indicators of a company’s sustainability performance due to the breadth of companies included, and the extensive and rigorous nature of their annual sustainability assessment.
Amgen was recently rated as one of the leading companies in the U.S. for workplace health and wellness in the 2019 Workplace Health Achievement Index from the American Heart Association (AHA). Of the more than 900 organizations that completed this year’s assessment, 27% received a gold rating by scoring at least 175 points on the index. Amgen’s score of 209 out of 217 points puts it among the highest ranked companies on the index. See heart.org/workplacehealth for more information.
Amgen was ranked No. 43 on the 18th Annual “Top 50 Employers” in STEM Workforce Diversity magazine. This list is the result of an annual reader survey mailed to randomly selected readers of STEM Workforce Diversity magazine. The readers of STEM Workforce Diversity magazine selected the top employers in the country for which they would most prefer to work or believe would provide a positive working environment for science, technology, engineering and math (STEM) professionals who are members of minority groups, women and people with disabilities.
Amgen—together with local healthcare partners in 10 countries around the world—set a Guinness World Records title for the most osteoporosis screenings for an osteoporosis campaign in 24 hours—with 6,056 tracked screenings on May 5, 2019. To break the existing world record, Amgen set out to screen at least a total of 3,000 people in 10 countries around the world—to help them understand their risk of having osteoporosis, a medical condition that weakens bones and makes them more likely to fracture. The campaign took place in Brazil, Canada, Colombia, Egypt, Kuwait, Lebanon, Mexico, Saudi Arabia, South Africa and Turkey.
Amgen is named among the top 100 companies in the Forbes Magazine 2019 America’s Best Employers for Diversity list for the second year in a row. Amgen was ranked #61 out of the 250 employers listed in the ranking, which was created from a survey of 50,000 U.S. employees’ perceptions of companies’ diversity and inclusion initiatives, gender split of senior management and board members, and proactive diversity communications.
Amgen has again earned a perfect score of 100% on the 2019 Corporate Equality Index (CEI), a national benchmarking tool on corporate policies and practices related to lesbian, gay, bisexual, transgender and queer (LGBTQ) workplace equality. The CEI is administered by the Human Rights Campaign (HRC) Foundation, the educational arm of the nation’s largest LGBTQ civil rights organization.
Amgen has been named one of Institutional Investors’ Most Honored Companies. America’s Most Honored Companies awards celebrate the U.S. companies who ranked at the top for their corporate leadership and investor relations expertise as voted on by the buy- and sell-side analyst community.
For the fourth year in a row, Amgen is one of the happiest companies in America, landing in the #9 spot. CareerBliss compiled the rankings from analyzing reviews of more than 200,000 companies to create the BlissScore, which is composed of company culture, leadership, overall work atmosphere and one's relationship with coworkers.
Amgen’s migraine treatment has been named one of TIME Magazine’s “Best Inventions of 2018.”
Amgen is ranked #44 among America's 500 Best Large Employers for 2018. To compile the listings, research firm, Statista, surveyed more than 30,000 American workers at large U.S. companies to understand how likely they were to recommend their organization to friends or family.
Amgen is named one of the “JUST 100” by Forbes Magazine and Just Capital in their 2018 rankings of America’s Most Just Companies. Amgen is listed #6 among the pharmaceuticals and biotech sector. To produce the rankings, Just Capital identified and polled Americans on key issues and priorities that define just business behavior.
Amgen is ranked #4 on Indeed.com's top rated healthcare companies for 2018. The ranking was created by analyzing employee reviews on the Indeed platform. Amgen employees cited opportunities for professional growth, culture and mission to serve patients as favorable reasons to work at Amgen.
Amgen is ranked #51 overall and #4 in the Drugs & Biotechnology category on Forbes Magazine’s inaugural America’s Best Employers for Diversity list. The ranking is created from a survey of 30,000 U.S. employees on their perceptions of companies’ diversity & inclusion initiatives, gender split of senior management and board members and proactive diversity communications.
For the fifth consecutive year, Amgen earned placement on the Dow Jones Sustainability Indices (DJSI) World Index. Amgen was additionally named to the North America Index for a sixth year. The DJSI Indices are among the most robust and reliable indicators of a company’s sustainability performance due to the breadth of companies included, and the extensive and rigorous nature of their annual sustainability assessment.
Amgen has earned a perfect score of 100% on the 2018 Corporate Equality Index (CEI), a national benchmarking tool on corporate policies and practices pertinent to lesbian, gay, bisexual, transgender and queer (LGBTQ) staff. The CEI is administered by the Human Rights Campaign (HRC) Foundation, the educational arm of the nation’s largest LGBTQ civil rights organization.
For the third year in a row, Amgen is one of the top 5 happiest companies in America and the top in the biopharma industry. CareerBliss compiles the rankings from 41,000 reviews to create the BlissScore, which is composed of "company culture, leadership, overall work atmosphere, and one's relationship with coworkers."
FORBES magazine has ranked Amgen among America’s 500 Best Large Employers of 2017. The company is listed as #2 in Biotech and #104 overall. To compile the listings, FORBES surveyed more than 30,000 workers at large U.S. companies to understand how likely they were to recommend their organization to friends or family.
Amgen has earned the CEO Cancer Gold Standard re-accreditation from the CEO Roundtable on Cancer, a nonprofit organization of executives dedicated to bringing bold and imaginative solutions to cancer treatment and prevention. To earn Gold Standard accreditation, an employer must establish programs to reduce cancer risk by taking concrete actions in five key areas including prevention, screening, cancer clinical trials, quality treatment and survivorship and health education and health promotion. Amgen was originally accredited in 2014.
The United States Environmental Protection Agency (EPA) has honored Amgen with a 2017 Green Chemistry Challenge Award. The EPA recognized Amgen as a green chemistry innovator for its work, in conjunction with its manufacturing partner, Bachem, in applying green-chemistry practices in the manufacture of the synthetic peptide drug Parsabiv™ (etelcalcetide).
For the fourth year in a row, Amgen has earned placement on the Dow Jones Sustainability Indices (DJSI) World Index. Amgen was additionally named to the North America Index for the fifth consecutive year. The Indices are considered to be among the most robust and reliable indicators of a company’s sustainability performance due to the breadth of companies included, and the extensive and rigorous nature of their annual sustainability assessment.
A team of Amgen engineers has been awarded the 2017 Energy Project of the Year: International award from the Association of Energy Engineers (AEE). The award recognizes a project that has achieved prominence in promoting energy engineering and management. Amgen was presented with the award for our "first-of-a-kind approach" on an advanced data analysis initiative, the Smart and Integrated Facility (SaIF) program.
Amgen has earned a top spot (#4) on BioSpace’s first annual Life Sciences Ideal Employer Report. BioSpace surveyed more than 2,400 life science professionals globally and out of 1,100 identified companies, the top 30 were highlighted for offering the “opportunity to do interesting and meaningful work, competitive salary, and a good reputation.”
For the second year in a row, Amgen has landed as the #2 Happiest Company in America on the annual CareerBliss 50 Happiest Companies in America awards listing. CareerBliss creates their rankings based on feedback from staff who submit reviews on the CareerBliss website.
Amgen has received a perfect score of 100 percent on the 2017 Corporate Equality Index (CEI), a national benchmarking survey and report on corporate policies and practices related to LGBT workplace equality, administered by the Human Rights Campaign Foundation. Amgen joins the ranks of 517 major U.S. businesses which also earned top marks this year.
Amgen was once again named as a 2017 Reader’s Choice in the Top 50 Employers category in CAREERS & the disABLED magazine. Readers were asked to name the employers, both private and public sectors, for whom they would most like to work or that they believe would provide a progressive environment for people with disabilities.
Amgen was named as a 2017 Readers’ Choice in the Top 50 Employers category in Minority Engineer magazine. Readers nominated the companies for which they would like to work and those that they believed provide positive working environment for minority engineers.
Amgen was named as a 2017 Readers’ Choice in the Top 50 Employer category in Woman Engineer magazine. The readers of Woman Engineer magazine selected the top companies in the country for which they would most like to work or whom they believe would provide a positive working environment for women engineers. This list is the result of an annual reader survey mailed to randomly selected readers of Woman Engineer magazine.
Amgen has been named to Corporate Responsibility Magazine’s 18th annual list of Best Corporate Citizens. The rankings are based on seven categories and 260 data points.
Amgen was honored as best workplace in Europe 2017 by the Great Place to Work Institute ranking #8 among multinationals and #2 in the pharma/biotech category. Great Place to Work® assesses organizations and selects great workplaces based on employees’ perceptions of their workplace experience and an analysis of the practices that underpin the organization’s workplace culture. More than 2,340 companies participated in 2017 in the national studies, across 19 countries.
Neulasta® (pegfilgrastim) Onpro® (On-body Injector) won the Drug-Delivery and Combination Products category (“gold winner”) at the 2017 Medical Device Excellence Awards (MDEA). MDEA is the premier awards program for the medtech industry. Entries for the annual awards are accepted in 9 product categories, and the judging is conducted by an impartial panel of jurors, composed of clinicians, engineers and designers.
Amgen has been independently assessed according to the FTSE4Good criteria, and has satisfied the requirements to become a constituent of the FTSE4Good Index Series. Created by the global index provider FTSE Russell, the FTSE4Good Index Series is designed to measure the performance of companies demonstrating strong Environmental, Social and Governance (ESG) practices. The FTSE4Good indices are used by a wide variety of market participants to create and assess responsible investment funds and other products.
Fast Company magazine has recognized Amgen as a Most Innovative Company for 2016. Amgen ranked 18th on the 50 Most Innovative Companies list and 3rd in the Biotech sector.
BLINCYTO® (blinatumomab) earned a prestigious Prix Galien Award in Russia. The Prix Galien Award is one of the highest accolades globally for innovation in pharmaceutical research and development.
BLINCYTO® (blinatumomab) earned a prestigious Prix Galien Award in Poland. The Prix Galien Award is one of the highest accolades globally for innovation in pharmaceutical research and development.
Amgen has again been named one of the Business Insider 50 Best Companies to Work for in America, ranking 12th among all American companies listed and 5th among healthcare companies. Business Insider noted that 90 percent of Amgen's worldwide employees reported having "high job meaning," and cited the fact that Amgen has made a commitment to development and education opportunities including tuition reimbursement as well as training and development opportunities on the job. The list was created by ranking the Fortune 500 using PayScale's salary and survey database, with final scores determined by multiplying six criteria: high job satisfaction, low job stress, ability to telecommute, high job meaning, experienced median pay, and salary delta (how the median pay compares to other companies in the same industry).
For the third year in a row, Amgen has earned placement on the Dow Jones Sustainability Indices (DJSI) World Index. Amgen was additionally named to the North America Index for the fourth consecutive year. The Indices are considered to be among the most robust and reliable indicators of a company’s sustainability performance due to the breadth of companies included, and the extensive and rigorous nature of their annual sustainability assessment.
Amgen placed among the top 100 in the U.S. and Global Newsweek Green Rankings for 2016. The rankings are the magazine’s annual evaluation of environmental and sustainability performance of the largest companies in the U.S. and the world.
Amgen was honored with two leading Pharma Industry Awards for 2016 for its operations in Ireland: Biopharma Company of the Year and the overall Pharma Industry Company of the Year. The Pharma Industry Awards recognize the most original and innovative companies that demonstrate excellence in the Irish Pharma sector.
Amgen has earned the CEO Cancer Gold Standard re-accreditation from the CEO Roundtable on Cancer, a nonprofit organization of executives dedicated to bringing bold and imaginative solutions to cancer treatment and prevention. To earn Gold Standard accreditation, an employer must establish programs to reduce cancer risk by taking concrete actions in five key areas including prevention, screening, cancer clinical trials, quality treatment and survivorship and health education and health promotion. Amgen was originally accredited in 2014.
Amgen has been named to Corporate Responsibility (CR) Magazine's 17th annual list of 100 Best Corporate Citizens.
Amgen received the "Resilient Supply Chain Industry Leader of the Year—Life Sciences" award for 2016. The award, presented by the Global Supply Chain Resiliency Council, recognized Amgen as a leader and role model in advancing supply chain risk management (SCRM) and resiliency discipline both within the company and across the industry.
Amgen was ranked 20th among Gartner's annual Healthcare Supply Chain Top 25 rankings for 2016. The ranking recognizes companies across the healthcare value chain that demonstrate leadership in improving human life at sustainable costs.
Amgen ranked #23 on the 15th Annual “Top 50 Employers” in STEM Workforce Diversity Magazine. This list is the result of an annual reader survey mailed to randomly selected readers, who were asked to select the top companies in the country for which they would most prefer to work or believe would provide a positive and inclusive working environment for engineers and IT professionals.
Amgen leads Glassdoor’s list of the “25 Highest Rated Companies for Vacation and Paid Time Off,” being selected #1 by those surveyed.
Amgen ranked #1 Best Healthcare Company to Work For in America and #3 Best Employer in America on the list, which was created by ranking the Fortune 500 using PayScale's salary and survey database. Final scores were determined by multiplying six criteria: high job satisfaction, low job stress, high work-schedule flexibility, high job meaning, experienced median pay, and salary delta (how the median pay compares to other companies in the same industry).
Amgen ranked 21st in the U.S. ranking and 34th in the Global rankings. The Newsweek Green Rankings are one of the world's most recognized assessments of corporate environmental performance. The rankings are based around eight indicators used to assess and measure the environmental performance of the world's largest publicly-traded companies, including: energy productivity (revenue divided by energy use), greenhouse gas productivity, water productivity, combined waste productivity, green pay linkage, green revenue scores, audited environmental metrics and the presence of a sustainability board committee.
Amgen has earned placement on both the Dow Jones Sustainability World Index and on the North America Index in 2015. It's Amgen's third year to make the North American Index and the second year in which it made the highly selective World Index. The Dow Jones Sustainability Indices (DJSI) are the world's first and most respected indices measuring sustainability performance.
The MIT Technology Review has ranked Amgen #19 on its list of 50 Smartest Companies for 2015. According to the Review's website: "To make the list, a company must have truly innovative technology and a business model that is both practical and ambitious."
In 2015, Amgen re-entered the Gartner's Supply Chain Life Sciences Top 25 rankings, positioned number five out of 11 companies Gartner ranked in the life sciences category. Gartner leads the field for assessment and ranking for supply chain. In creating their rankings, Gartner looks at criteria such as risk mitigation efforts, supply chain segmentation, data management, supplier management efforts, emerging market expansion, logistics and inventory management, multi-enterprise collaboration, and talent acquisition.
Amgen was included on the 2015 list, which features the top 10 leading pipelines within the entire pharma and biotech arena. The list takes into account headliner new drug approvals during 2014 as well as the most exciting drug prospects.
Amgen ranked #9 on the 2015 list, which honors the top companies dedicated to creating happier work environments - as voted for by their own employees. CareerBliss analyzed thousands of independent company reviews from visitors of CareerBliss.com to determine which companies have the happiest workers.
Amgen was awarded 2015 Best Biotech Company, as part of Medreps.com 4th Annual Best Places to Work in Medical Sales survey of 1,400 medical sales professionals. Important survey considerations cited for a company to be a desirable workplace included solid product line, competitive compensation and positive work-life balance.
Amgen ranked #46 on the 2015 list. Readers of Minority Engineer magazine were asked to name the employers, both in the private and public sectors, for whom they would most like to work or that they believe would provide a positive working environment for members of minority groups.
Amgen ranked #28 on the 2015 list. Readers of Careers & the disABLED magazine were asked to name the employers, both private and public sectors, for whom they would most like to work or that they believe would provide a progressive environment for people with disabilities.
Amgen ranked #37 on the 2015 list. Readers of Equal Opportunity magazine were asked to name the employers, both in the private and public sectors, for whom they would most like to work or that they believe would provide a positive working environment for members of minority groups.
Amgen ranked #42 on the 2015 list. Readers of Woman Engineer magazine were asked to name the employers, both in the private and public sectors, for whom they would most like to work or that they believe would provide a positive working environment for women.
Amgen Austria topped the 2015 "Great Places to Work in Austria" list among other nominated companies in the medium category. Amgen Austria staff were invited to participate in an online survey about working at Amgen, where 97 percent of the team participated and unanimously said that "Amgen Austria is a great place to work."
Amgen ranked #24 on the 2014 list, up from the #25 spot in 2013. Barron's has been surveying institutional investors annually since 2005 about their views of the world's 100 largest companies, as measured by total stock market capitalization. The participants were asked to select one of four statements reflecting their view of each company: Highly Respect, Respect, Respect Somewhat, or Don't Respect.
This list includes the 20 companies with the best reputations as employers and the top three driving characteristics for each company, according to survey respondents. Amgen was ranked #18 with driving characteristics of "innovative leader in the industry," "treats employees with respect," and "is socially responsible.
Amgen ranked 20th Best Employer in America on the 2014 list, which is created by ranking the Fortune 500 using PayScale's salary and survey database. Final scores were determined by multiplying six criteria: high job satisfaction, low job stress, high work-schedule flexibility, high job meaning, experienced median pay, and salary delta (that is, how the median pay compares with other companies in the same industry).
Amgen earned placement in the Dow Jones Sustainability World Index for the first time and again was named to the North America Index. Amgen was considered to be one of the three largest additions to the World Index for the year (by free-float market capitalization).
Amgen received CEO Cancer Gold Standard accreditation from the CEO Roundtable on Cancer, a nonprofit organization of executives founded by former President George H.W. Bush.
Amgen ranked #23 on the 2014 list. Readers of Equal Opportunity magazine were asked to name the employers, both in the private and public sectors, for whom they would most like to work or that they believe would provide a positive working environment for members of minority groups.
Amgen ranked #17 on the 2014 list. Readers of Woman Engineer magazine were asked to name the employers, both in the private and public sectors, for whom they would most like to work or that they believe would provide a positive working environment for women.
The U.S. Green Building Council recognized Amgen's building design strategy by certifying our innovative drug-product development building at our Thousand Oaks, California campus at the highest level—LEED (Leadership in Energy and Environmental Design) Platinum. This is Amgen's third LEED certification.
The Association of Energy Engineers (AEE) awarded Amgen with its top honor, the Corporate Energy Management Award. The AEE honors companies with this award that have made important investments in energy management while generating sustained improvement.
Southern California Edison and The Climate Registry recognized Amgen with a 2014 Cool Planet Award for outstanding environmental leadership in energy and carbon management.
The Puerto Rico Manufacturers Association awarded Amgen Manufacturing, Limited (AML) with a 2014 Quest Award. AML earned a first place in the energy category for excellence in energy conservation.
The Massachusetts Department of Transportation awarded Amgen with a 2014 Excellence in Commuter Options Award at the Leader level. The awards recognize companies that promote healthier, more environmentally friendly commuting options.
The Rhode Island Hospitality and Tourism Association and the Rhode Island Department of Environmental Management granted a Certification of Participation to Amgen's Rhode Island facility for "attaining performance standards, implementing best management practices, and complying with environmental regulatory requirements" in facility operations.
The Ventura County Coalition for Coastal and Inland Waterways honored Amgen volunteers for their contribution to the removal of 9,681 pounds of trash for the region's International Coastal Cleanup event.
Amgen was ranked #1 out of all small organizations on the 2014 list. The Best Workplaces in Finland 2014 list was comprised of three categories: small organizations (15-49 employees), general category (50-499 employees) and large organizations (500 employees or more). Altogether, 138 organizations participated in the list process, representing more than 45,000 employees.
Amgen was ranked #45 on the 2014 list. This ranking was the result of a rigorous process that analyzes and assesses the views of employees and the corporate culture of each company. In Mexico, the Methodology Model and Great Place to Work are certified by the Mexican Institute of Standardization and Certification (Instituto Mexicano de Normalización y Certificación A.C.).
Amgen was ranked #6 on the 2014 list. The list, created by Great Place to Work® Institute Hellas with the academic cooperation of ALBA Graduate Business School, had 54 companies participate in the survey, with an anonymous questionnaire sent to almost 11,000 employees.